将血压素和皮质作为败血症冲击中的辅助措施进行比较
Hannah F Wang1, Beena Cheriyan2, Marianne Huebner3,4
1Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
The Annals of pharmacotherapy
|January 7, 2026
概括
早期用皮素作为上腺素的辅助剂在败血症休克中,与血管压素相比,与降低住院死亡率有关. 这一发现表明,皮可能会改善结果,特别是当迅速开始为患者增加的北上腺素需求.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 上腺素是血动力学支持在败血性休克的主要药物.
- 作为辅助疗法的血压素和皮的最佳时间和顺序仍在争论中.
- 新出现的证据表明,早期皮可能会降低死亡率.
研究的目的:
- 为了比较血管压素与水皮质作为在败血症休克中对诺拉上腺素的辅助剂的有效性和安全性.
- 评估初始辅助剂选择对患者结果的影响.
主要方法:
- 在ICU的成年败血症休克患者的多中心,回顾性,观察性研究.
- 两个队列:最初的辅助治疗是使用压素或皮质后的上腺素.
- 主要结局:住院死亡率;次要结局:重症监护室/住院时间长度,血管压缩剂中止,脏替代疗法,安全性.
主要成果:
- 皮激素组 (n=193) 的住院死亡率 (37.3%) 低于血管压素组 (n=435,53.3%).
- 调整后的死亡风险比为1.80 (95% CI 1.19-2.74,P=0.006).
- 皮与较短的医院LOS和较少的RRT启动有关.
结论:
- 作为上腺素的初始辅助剂,上腺素在败血症休克中与相比于血管压素的医院死亡率降低有关.
- 早期启动皮可能会改善败血症休克的临床结果.
- 在患有不断升级的北上腺素需求的患者中,考虑早期的皮松.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177
Antihypertensive Drugs: Vasodilators
2.0K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.0K
Cardiopulmonary Resuscitation IV: Pharmacological Management
639
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
639


